Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx | Zendy

Fabrice André | Zendy; Nofisat Ismaila | Zendy; N. Lynn Henry | Zendy; Mark R. Somerfield | Zendy; Robert C. Bast | Zendy; William E. Barlow | Zendy; Deborah Collyar | Zendy; M. Elizabeth Hammond | Zendy; Nicole M. Kuderer | Zendy; Minetta C. Liu | Zendy; Catherine Van Poznak | Zendy; Antonio C. Wolff | Zendy; Vered Stearns | Zendy

Open Access

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx

Author(s) -

Fabrice André,

Nofisat Ismaila,

N. Lynn Henry,

Mark R. Somerfield,

Robert C. Bast,

William E. Barlow,

Deborah Collyar,

M. Elizabeth Hammond,

Nicole M. Kuderer,

Minetta C. Liu,

Catherine Van Poznak,

Antonio C. Wolff,

Vered Stearns

Publication year - 2019

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.19.00945

Subject(s) - medicine , guideline , breast cancer , systemic therapy , disease , adjuvant therapy , oncology , hormonal therapy , cancer , stage (stratigraphy) , hormone therapy , clinical trial , clinical practice , gynecology , family medicine , pathology , paleontology , biology

This focused update addresses the use of Onco ype DX in guiding decisions on the use of adjuvant systemic therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research